MedTrace Logo

Implementation of Shared Decision-Making in Cancer Care

NCT03393351 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2131

Last updated 2021-06-04

No results posted yet for this study

Summary

This study aims to evaluate a theoretically and empirically grounded implementation program designed to foster shared decision-making in routine cancer care. The intervention program consists of several components (e.g. training for health care professionals, patient empowerment strategies) that will be rolled out in three clinics at a comprehensive cancer center in Germany.

Conditions

Interventions

OTHER

Shared decision-making program

The intervention is shared decision-making. The implementation strategy to foster shared decision-making in routine cancer care is a multicomponent implementation program. The implementation program consists of the following components: 1. shared decision-making trainings for health care professionals, 2. individual coaching for physicians, 3. patient activation strategy, 4. provision of patient information material and decision aids, 5. revision of the clinics quality management documents, and 6. critical reflection of current organization of multidisciplinary team meetings. Implementation: after baseline assessment (t0) for clinic 1, after assessment at t1 for clinic 2, after assessment at t2 for clinic 3.

OTHER

Usual Care

No specific study related intervention. Treatment decisions are made according to current routine practice at the comprehensive cancer center in Germany.

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Isabelle Scholl, Dr. · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-05
Primary Completion
2020-09-12
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03393351 on ClinicalTrials.gov